">

FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit

News

FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit

14/10/2024 0 Comment
Share
Like

STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests

Source

Search

Blog Categories

Blog Popular